Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer

The management of advanced castration resistant prostate cancer (CRPC) has been rapidly changing and is still evolving. In the last years, there has been an increasing knowledge of prostate cancer biology. New therapeutic agents and approaches have been evaluated demonstrating benefits in survival a...

Descripción completa

Detalles Bibliográficos
Autores principales: Recine, Federica, Sternberg, Cora N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708230/
https://www.ncbi.nlm.nih.gov/pubmed/26816835
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.11
_version_ 1782409425865146368
author Recine, Federica
Sternberg, Cora N.
author_facet Recine, Federica
Sternberg, Cora N.
author_sort Recine, Federica
collection PubMed
description The management of advanced castration resistant prostate cancer (CRPC) has been rapidly changing and is still evolving. In the last years, there has been an increasing knowledge of prostate cancer biology. New therapeutic agents and approaches have been evaluated demonstrating benefits in survival and quality of life in patients with metastatic prostate cancer.
format Online
Article
Text
id pubmed-4708230
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-47082302016-01-26 Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer Recine, Federica Sternberg, Cora N. Transl Androl Urol Review Article The management of advanced castration resistant prostate cancer (CRPC) has been rapidly changing and is still evolving. In the last years, there has been an increasing knowledge of prostate cancer biology. New therapeutic agents and approaches have been evaluated demonstrating benefits in survival and quality of life in patients with metastatic prostate cancer. AME Publishing Company 2015-06 /pmc/articles/PMC4708230/ /pubmed/26816835 http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.11 Text en 2015 Translational Andrology and Urology. All rights reserved.
spellingShingle Review Article
Recine, Federica
Sternberg, Cora N.
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
title Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
title_full Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
title_fullStr Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
title_full_unstemmed Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
title_short Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
title_sort hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708230/
https://www.ncbi.nlm.nih.gov/pubmed/26816835
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.11
work_keys_str_mv AT recinefederica hormonaltherapyandchemotherapyinhormonenaiveandcastrationresistantprostatecancer
AT sternbergcoran hormonaltherapyandchemotherapyinhormonenaiveandcastrationresistantprostatecancer

Ejemplares similares